Supernus Pharmaceuticals Inc (NAS:SUPN)
$ 48.21 +1.15 (+2.44%) Market Cap: 2.80 Bil Enterprise Value: 2.47 Bil PE Ratio: 0 PB Ratio: 2.71 GF Score: 74/100

Supernus Pharmaceuticals Inc (SUPN) Transcripts

  • 1